Berenberg downgraded Nike to Sell and cut its price target to $27.50, arguing that weak sportswear demand and pressure in China could extend the recovery. The rating is one analyst's view. Nike's own first-quarter results show why the debate has shifted from cost cutting to the pace of brand and channel repair.
Performance is improving before lifestyle
Nike said its Sport Offense strategy was producing measurable progress in performance categories. At the same time, management acknowledged more work in Nike Sportswear, Jordan Brand and Greater China. That split matters because performance innovation can improve brand heat without immediately restoring the much larger lifestyle business.
Fiscal first-quarter revenue was $11.2 billion and diluted earnings were $0.48 per share. Nike Direct revenue fell to $4.1 billion from $4.5 billion a year earlier, while wholesale revenue was $6.8 billion and down 1% on a currency-neutral basis. The channel mix shows that the turnaround is not yet broad-based.
The company is changing how it operates
Nike introduced an operating-model program called Pace and expects adjusted fiscal 2027 earnings of $1.15 to $1.35 per share, excluding restructuring expenses. Cost savings can support profit, but they cannot replace product demand. Inventory discipline, full-price sales and gross margin will show whether the company is rebuilding pricing power.
China remains a separate challenge
Greater China faces local competitors, changing consumer tastes and uneven traffic. Improvement there requires products and distribution that fit the market, not only global campaigns. A weaker result in China can offset progress in North America or running.
What investors should watch
The next quarter should be judged on currency-neutral sales in Nike Direct, Sportswear, Jordan and Greater China, along with gross margin and inventory. Investors should also separate restructuring savings from underlying revenue improvement.
BTI's bottom line
The downgrade captures a real risk: Nike's strongest performance categories have not yet repaired the full portfolio. The stock needs evidence that demand, not just lower costs, is stabilizing the business.